These 6 genes were chosen because of their overrepresentation in oncogenic pathways for EGF, FGF, mTOR, and integrin signaling (see Supplemental Figure S4), and because they were not identified in the ChIP-chip study on CA PCa cell line LNCaP [77]. Here, MTOR is linked to cancer.